Cargando…
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma
SIMPLE SUMMARY: RM-1929 near-infrared photoimmunotherapy (NIR-PIT) is an emerging treatment that is currently being investigated under a world-wide Phase III clinical trial and has been conditionally approved for the treatment of unresectable and/or recurrent HNSCC in Japan since 2021. Disease contr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650558/ https://www.ncbi.nlm.nih.gov/pubmed/37958293 http://dx.doi.org/10.3390/cancers15215117 |